Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in HER2-negative Breast Cancer
NCT00616967Phase 2Active, not recruiting
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- May 2008
- Primary completion
- Jun 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started May 2008; status: active, not recruiting.
02
Drugs
vorinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00616967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616967.